SCHEMBL23710060

SCHEMBL23710060

NCC[C@H]1CNCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL185653 1.00 — —
Hydrazine SCHEMBL8554314 0.98 SLC6A2 (0.38) —
Hydrochloric Acid SCHEMBL6025691 0.98 SLC6A4 (0.39) —
Morpholine SCHEMBL5147043 0.92 MEN1 (0.39) —
SCHEMBL72780 0.88 SLC6A2 (0.37) —
SCHEMBL20929877 0.88 SLC6A2 (0.37) —
SCHEMBL1746181 0.86 SLC6A2 (0.42) —
Hydrazine SCHEMBL8557573 0.86 SLC6A2 (0.36) —
SCHEMBL8557599 0.86 SLC6A2 (0.36) —
SCHEMBL9149862 0.84 EPHX1 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3858832-A1 TRIFLUOROMETHYL-SUBSTITUTED SULFONAMIDE AS BCL-2-SELECTIVE INHIBITOR Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) 2021-08-04 — — EP disclosed
CN-108884070-A PYRIDYL DERIVATIVES AS BROMODOMAIN INHIBITORS 葛兰素史克知识产权第二有限公司 2018-11-23 — — CN disclosed
Send feedback